Neuroproteomics as a Tool for Understanding Schizophrenia

Neuroproteomics has revealed molecular features of schizophrenia and potential biomarkers for diagnosis and medication monitoring. Edited by a leader in the field, it will provide evidence for developing innovative future treatment strategies.

Format: Hardback
Length: 143 pages
Publication date: 06 August 2022
Publisher: Springer Nature Switzerland AG

Over the past decade, neuroproteomics has emerged as a powerful tool in unraveling the intricate molecular mechanisms underlying schizophrenia. By providing a comprehensive understanding of the biological processes involved in the development, maintenance, and treatment of this disorder, these studies have paved the way for the identification of potential biomarkers that can aid in the diagnosis and monitoring of medication responses.

Edited by a renowned expert in the field of neuroproteomics, this cutting-edge volume brings together contributions from esteemed subject experts. It offers a comprehensive overview of recent findings and consolidates evidence from diverse perspectives, including human samples, animal models, and pluripotent stem cell-derived in vitro pre-clinical models. By presenting a multifaceted view of schizophrenia, this book aims to provide valuable insights that can inform the development of innovative and effective future treatment strategies.

This volume is of immense value to a wide range of researchers and professionals, including biologists, neurologists, psychiatrists, analytical chemists, and pharmacists, among others. It serves as a comprehensive resource for those seeking to deepen their understanding of schizophrenia and explore new avenues for therapeutic intervention.

The chapters in this book are organized in a logical and accessible manner, making it easy for readers to navigate and gain a comprehensive understanding of the latest research in neuroproteomics and schizophrenia. Each chapter begins with an introduction that provides a brief overview of the topic, followed by detailed explanations and illustrations that help to clarify complex concepts.

The authors of this volume have made a significant contribution to the field by compiling a wealth of evidence from diverse sources and presenting it in a clear and concise manner. Their expertise and dedication to advancing our understanding of schizophrenia are evident in every page, and this book is sure to become a valuable resource for researchers, clinicians, and policymakers alike.

In conclusion, neuroproteomics has revolutionized our understanding of schizophrenia by shedding light on the molecular mechanisms underlying this disorder. This new volume, edited by a leading expert in the field, provides a comprehensive and up-to-date overview of recent findings and offers valuable insights into the development of innovative treatment strategies. By fostering interdisciplinary collaboration and promoting a deeper understanding of schizophrenia, this book will undoubtedly contribute to the advancement of mental health research and patient care.

Weight: 496g
Dimension: 254 x 178 (mm)
ISBN-13: 9783030971816
Edition number: 1st ed. 2022